Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pemetrexed × 1 year × Clear all

Phase

Phase 2 89 Phase 3 87 Phase 1/2 38 Phase 1 32 Phase 2/3 9 Phase NA 3 Phase 4 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non-Small Cell Lung Cancer Metastatic 1

Interventions

Dexamethasone 11 Fluorouracil 8 Carboplatin 8 Saline Solution 7 Human Papillomavirus Recombinant Vaccine nonavalent 7 Bupivacaine 7 pembrolizumab 6 anlotinib 6 Tobacco Use Cessation Devices 6 Magnetic Resonance Spectroscopy 6 Lenalidomide 6 Standard of Care 5 Specimen Handling 5 Propofol 5 Prednisone 5 Nivolumab 5 Cisplatin 5 Bortezomib 5 Bevacizumab 5 trametinib 4 lenvatinib 4 enzalutamide 4 dabrafenib 4 cabozantinib 4 Sodium Chloride 4 Ropivacaine 4 Rituximab 4 Paclitaxel 4 Imatinib Mesylate 4 Esomeprazole 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05689671 2026-03-10

ANTELOPE

Charite University, Berlin, Germany

Phase 4 Active not recruiting

Non-Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡